![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
CASE REPORT
Chirurgia 2021 August;34(4):174-7
DOI: 10.23736/S0394-9508.20.05104-9
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Diffuse large B-cell lymphoma of the breast
Federica ROCCO ✉, Sara MASTROIANNI, Annunziata ALLOCCA, Fabio PROCACCINI, Roberta ALBACHIARA, Antonella SCIARRA, Eugenio PROCACCINI
Breast Unit, Department of Advanced Medical and Surgical Sciences, Luigi Vanvitelli University of Campania, Naples, Italy
Primary breast lymphoma (PBL) is a very rare pathological entity, representing only 0.04-0.5% of all breast malignancies, approximately 0.38-0.70% of all non-Hodgkin lymphomas (NHL) and 1.7-2.2% of all extranodal NHL. In this study we report the case of an elderly patient, addressed to our Breast Unit in September 2018 for a mass in the right breast. DLBCL is the most common subtype of PBL; it has the worse prognosis, in addition to a significantly higher risk of contralateral breast involvement. PBLs do not show distinctive features in conventional imaging techniques. Only core needle biopsy or surgical biopsy can provide essential elements for diagnosis and immunohistochemical assessment. Several Authors demonstrate that mastectomy is unnecessary, with no benefits in terms of survival and recurrence. Surgical resection should be conservative but adequate at the same time, in order to provide an R0 removal. These tumors are highly sensitive to chemotherapy and radiotherapy. Breast lymphoma represents a diagnostic challenge. We report a clinical case of DLBCL, our therapeutic choice and our treatment respecting the recent medical literature.
KEY WORDS: Lymphoma; Lymphoma, large B-cell, diffuse; Lymphoma, non-Hodgkin; Breast neoplasms